Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Kymera Therapeutics Director Executes Stock Option Exercise and Sale

Kymera Therapeutics Director Executes Stock Option Exercise and Sale

Elena Ridloff, a director at Kymera Therapeutics, Inc. (NASDAQ: KYMR), has completed a series of transactions involving the exercise of stock options and the subsequent sale of common stock. The activity, which took place on May 11, 2026, resulted in total proceeds of $261,000. These transactions were conducted under a pre-established Rule 10b5-1 t…

Planet Fitness Director Frances Rathke Executes $231,050 Stock Purchase Amid Mixed Analyst Outlook

Planet Fitness Director Frances Rathke Executes $231,050 Stock Purchase Amid Mixed Analyst Outlook

Frances Rathke, a member of the board of directors at Planet Fitness, Inc. (NASDAQ: PLNT), has increased her stake in the company through an indirect purchase of Class A common stock. The transaction, which took place on May 8, 2026, involved the acquisition of 5,000 shares at a price of $46.21 per share, representing a total investment of $231,050…

Comfort Systems USA Executive Executes $2.25 Million Stock Sale

Comfort Systems USA Executive Executes $2.25 Million Stock Sale

In a recent filing, it was disclosed that Julie Shaeff, the Chief Accounting Officer for Comfort Systems USA Inc. (NASDAQ: FIX), executed a sale of company stock totaling approximately $2.25 million. The transaction occurred on May 11, 2026, involving the sale of 1,123 shares of common stock at an average price per share of $2,000.37. Following thi…

DHI Group Director Executes Stock Sale Amid Year-to-Date Rally

DHI Group Director Executes Stock Sale Amid Year-to-Date Rally

Joseph G. Massaquoi Jr., a director at DHI Group, Inc. (NASDAQ: DHX), has completed a sale of common stock totaling $82,227. The transaction, which involved 26,611 shares, was executed on May 8, 2026. This divestment occurs against a backdrop of significant price appreciation for the company's stock throughout the current year and follows a period …

Castle Biosciences CEO Executes Rule 10b5-1 Transactions Involving Stock Sales and Option Exercises

Castle Biosciences CEO Executes Rule 10b5-1 Transactions Involving Stock Sales and Option Exercises

Derek Maetzold, the President and Chief Executive Officer of Castle Biosciences Inc. (NASDAQ: CSTL), completed a series of stock transactions on May 7, 2026. These transactions, which were conducted under a pre-established Rule 10b5-1 trading plan adopted in December 2025, involved both the sale of common stock and the acquisition of shares through…

Avalo Therapeutics CFO Executes Stock Transactions via 10b5-1 Plan

Avalo Therapeutics CFO Executes Stock Transactions via 10b5-1 Plan

Christopher Ryan Sullivan, the Chief Financial Officer of Avalo Therapeutics, Inc. (NASDAQ: AVTX), has completed a series of transactions involving the company's common stock. According to a Form 4 filing submitted to the Securities and Exchange Commission on May 11, 2026, these movements were conducted under a Rule 10b5-1 trading plan that Sulliva…